Amlodipine Cost in District of Columbia 2026

What Does Amlodipine Cost in DC in 2026?

Generic amlodipine tablets cost DC residents approximately $8 per month at most major retail pharmacies in 2026. That figure reflects a 30-day supply of 5 mg or 10 mg tablets purchased cash-pay without insurance. Pfizer's branded Norvasc carries a list price near $80 per month, but virtually no patient paying out of pocket needs to spend that amount given the wide availability of generics.

Prices vary by pharmacy, supply chain, and whether a discount card is applied. The table below summarizes typical 2026 DC pricing across common purchase channels.

| Channel | Estimated Monthly Cost (30-day supply) | |---|---| | Generic, retail cash-pay | ~$8 | | Branded Norvasc, list price | ~$80 | | GoodRx or similar discount card | $4, $10 | | DC Medicaid (with PA) | $0, $3 copay | | 503A compounded (qualifying program) | $0 |

Amlodipine's low cost reflects decades of generic competition since the original Norvasc patent expired. The FDA maintains an updated list of approved generic amlodipine manufacturers [1], and multiple suppliers keep the generic market competitive year-round.

A large part of amlodipine's clinical appeal is its well-established safety profile. The ASCOT-BPLA trial (N=19,257) published in The Lancet in 2005 found that an amlodipine-based regimen reduced the primary endpoint of nonfatal myocardial infarction and fatal coronary heart disease compared with an atenolol-based strategy (hazard ratio 0.90, P=0.0247) [2]. That evidence base supports continued prescribing, which in turn drives generic volume and keeps costs low.

The FDA-approved prescribing information for amlodipine besylate specifies starting doses of 5 mg once daily for hypertension, with titration to 10 mg once daily as needed [3]. Dose-dependent pricing is minimal at this drug's generic price point; the 5 mg and 10 mg tablets are often the same retail cost per tablet.

DC Medicaid Coverage for Amlodipine

DC Medicaid covers amlodipine, but the drug requires prior authorization (PA) before the plan will pay. PA is a step-therapy or clinical-criteria process, and most prescribers in DC manage it routinely for antihypertensive agents.

DC's Medicaid program operates through managed care organizations (MCOs) including AmeriHealth Caritas DC and MedStar Family Choice DC. Each MCO publishes its own formulary, but all must comply with DC Department of Health Care Finance coverage rules. Amlodipine is listed as a preferred generic on most DC Medicaid formularies once PA criteria are met, which typically require documentation of a hypertension or angina diagnosis.

The American Heart Association's 2023 hypertension guideline states: "Calcium channel blockers, including amlodipine, are among the four preferred first-line drug classes for hypertension in the general nonblack population." [4] That clinical backing strengthens PA approval odds for most patients.

After PA approval, DC Medicaid enrollees generally owe a nominal copay of $0 to $3 per fill, depending on their specific MCO benefit tier. Patients who are denied PA on first submission may appeal; DC Medicaid appeal timelines are governed by federal Medicaid managed care rules under 42 CFR §438.408, which require standard appeal decisions within 30 calendar days [5].

For enrollees in DC's Medicaid expansion population (adults up to 215% of the federal poverty level in DC), the effective cost after PA approval is often zero given DC's low fixed-copay structure for generic drugs [6].

Is Compounded Amlodipine Legal in DC?

Licensed 503A compounding pharmacies in DC may legally prepare and dispense compounded amlodipine for individual patients with a valid prescription. The FDA's 503A framework under the Drug Quality and Security Act (DQSA) of 2013 permits patient-specific compounding when a licensed prescriber writes the order and a licensed pharmacy fills it [7].

Compounding is not permitted as a workaround to replace commercially available generics at scale; that would fall under 503B outsourcing facility rules, which require FDA registration and operate under current good manufacturing practice (cGMP) standards [8]. For individual DC patients, 503A compounding is legal and available.

Why would a patient choose compounded amlodipine when the generic costs only $8 per month? Some telehealth-based prescribing programs bundle compounded amlodipine with other cardiovascular or metabolic agents and cover dispensing fees through subscription models, resulting in a $0 net cost to the patient for the amlodipine component. Others may need a non-standard dose form (liquid suspension for dysphagia) not commercially available.

The DC Board of Pharmacy licenses and oversees all compounding pharmacies operating in the district [9]. Patients should verify that any online pharmacy filling a compounded amlodipine prescription holds an active DC Board of Pharmacy license or holds reciprocal licensure in a state with equivalent oversight.

The FDA maintains a database of registered outsourcing facilities [10] and a list of drugs that have been placed on the "difficult to compound" list; amlodipine besylate tablets are not on that list as of 2025, meaning 503A compounding remains permissible [11].

Telehealth Prescribing of Amlodipine in DC

Amlodipine can be prescribed via telehealth in DC. DC law permits synchronous audio-video telemedicine encounters to establish the prescriber-patient relationship needed for a new prescription, including antihypertensives. The DC Medical Practice Act does not require an in-person visit before prescribing a non-controlled substance such as amlodipine [12].

The DC Department of Health issued guidance during the COVID-19 public health emergency that expanded telehealth access, and subsequent permanent rulemaking retained most of those provisions for non-controlled Schedule drugs. Amlodipine is not a scheduled controlled substance under the Controlled Substances Act [13], so no DEA-registration special authorization is needed for the telehealth visit.

Practically, a DC resident can complete a telehealth visit with a licensed DC prescriber (MD, DO, NP, or PA with prescriptive authority), receive an amlodipine prescription electronically, and fill it at any DC-licensed retail or mail-order pharmacy. The entire process, from account creation to pharmacy pickup, can occur in under 24 hours for most patients at established telehealth platforms.

Remote blood pressure monitoring strengthens telehealth management of hypertension. The TASMIN-SR trial (N=552) showed that self-monitored blood pressure with telemonitoring support lowered systolic BP by an additional 4.7 mmHg compared with usual care [14]. DC telehealth prescribers frequently recommend home BP cuffs validated by the British Hypertension Society or American Medical Association protocol.

Which Insurance Plans Cover Amlodipine in DC?

Most private insurance plans operating in DC cover generic amlodipine. The drug appears on Tier 1 (lowest-cost generic) of most commercial formularies, including plans sold through DC Health Link, DC's ACA marketplace exchange.

DC Health Link offers plans from carriers including Kaiser Permanente, CareFirst BlueCross BlueShield, and Aetna CVS Health [15]. On Tier 1 formularies, generic amlodipine typically costs $0, $10 per fill after deductible, depending on whether the patient has met their annual deductible and the plan's specific cost-sharing structure.

Employer-sponsored plans in DC follow similar formulary conventions. The National Committee for Quality Assurance (NCQA) HEDIS measure for controlling high blood pressure uses antihypertensive medication adherence as a quality metric, giving insurers an incentive to minimize cost barriers to drugs like amlodipine [16].

Medicare Part D covers amlodipine generics on most plan formularies. Under the Inflation Reduction Act's drug pricing provisions effective 2025, the Medicare Part D out-of-pocket cap is $2,000 per year, and generic tier drugs like amlodipine rarely push beneficiaries close to that cap [17]. DC residents enrolled in Medicare Advantage plans should check their Summary of Benefits and Coverage (SBC) document for the exact tier placement.

Medicare Savings Programs (MSPs), including the Low-Income Subsidy (LIS or "Extra Help"), further reduce or eliminate Part D cost-sharing for qualifying DC beneficiaries. SSA administers Extra Help applications, and DC residents can apply through the Social Security Administration online portal [18].

Discount Programs and Savings Cards in DC

Several programs reduce amlodipine costs to near zero for DC residents who are uninsured or underinsured.

GoodRx and NeedyMeds. Free discount card programs like GoodRx negotiate contracted rates at retail pharmacies. DC prices via GoodRx for a 30-day supply of generic amlodipine 5 mg range from approximately $4 to $10 depending on the pharmacy chain and ZIP code. These cards are accepted at CVS, Walgreens, Rite Aid, Giant Food Pharmacy, and most independent DC pharmacies.

Pfizer Patient Assistance. For patients who need branded Norvasc and meet income eligibility criteria, Pfizer's patient assistance program (Pfizer RxPathways) may provide the drug at no cost. The program covers patients at or below 400% of the federal poverty level who lack adequate insurance coverage [19].

DC Pharmaceutical Assistance Program. The DC Department of Health operates the DC Pharmaceutical Assistance Program for the Aged and Disabled (DCPAP), which assists DC residents aged 65 and older or those with disabilities who have limited incomes and do not qualify for DC Medicaid but face high drug costs [20]. Amlodipine, as a covered generic, is eligible under this program.

340B Drug Pricing Program. Federally qualified health centers (FQHCs) in DC, including Unity Health Care and Community of Hope, participate in the 340B program, which allows them to purchase outpatient drugs at significantly reduced prices and pass savings to eligible low-income patients [21]. DC residents receiving care at 340B-covered entities may access amlodipine at minimal or no cost.

Manufacturer Savings Card for Norvasc. Pfizer's savings card for branded Norvasc applies primarily to commercially insured patients. The card reduces the branded copay but does not typically benefit Medicaid enrollees or uninsured patients paying cash (in which case the generic is almost always cheaper anyway) [22].

How Amlodipine Works and Why It Costs What It Does

Amlodipine is a dihydropyridine calcium channel blocker. It blocks L-type voltage-gated calcium channels in vascular smooth muscle and cardiac muscle cells, causing vasodilation and reducing peripheral vascular resistance [23]. The resulting blood pressure reduction is dose-dependent: 5 mg once daily typically produces a 7 to 8 mmHg reduction in systolic BP, and 10 mg once daily produces a 10 to 12 mmHg reduction in most hypertensive populations [24].

The drug's long plasma half-life (30 to 50 hours) makes once-daily dosing effective and forgiving of occasional missed doses. That pharmacokinetic profile, documented in the FDA label, also means blood pressure control is smooth without the trough-peak swings seen with shorter-acting agents [3].

Generic pricing reflects patent expiration (original Norvasc patent expired in 2007) combined with high generic manufacturer competition. The FDA's Orange Book lists more than 30 approved generic amlodipine besylate products across multiple manufacturers [1]. That competition is the primary driver of the ~$8 DC retail price.

The ALLHAT trial (N=33,357), published in JAMA in 2002, compared amlodipine with chlorthalidone and lisinopril for hypertension. Amlodipine showed equivalent all-cause mortality and similar cardiovascular event rates, confirming its role as a first-line agent [25]. Combined with generic pricing, that evidence profile makes amlodipine one of the highest-value antihypertensives available.

The FDA approved amlodipine besylate (Norvasc) in 1992 for hypertension and for chronic stable angina and confirmed vasospastic angina [3]. Approved indications have not changed materially since, and the drug's long post-market safety record supports broad prescribing confidence.

Amlodipine Dosing, Side Effects, and Clinical Considerations Relevant to Cost

Understanding dose and side-effect profile helps DC patients and prescribers make cost-conscious treatment decisions.

Standard dosing is 5 mg orally once daily, titrated to 10 mg once daily after 7 to 14 days if BP targets are not reached [3]. The 2.5 mg starting dose is used in small or elderly patients or those with hepatic impairment; commercial generic 2.5 mg tablets are available but slightly less common, so confirm formulary listing before prescribing.

The most common dose-dependent side effect is peripheral edema (ankle swelling), occurring in approximately 10.8% of patients on 10 mg vs. 1.8% on placebo in registration trials [3]. Edema does not require drug discontinuation in most cases but may prompt a dose reduction to 5 mg, which affects cost only minimally at current generic prices.

Other notable effects include flushing and palpitations from vasodilation. Serious adverse events, including severe hypotension, are rare at therapeutic doses. Drug interactions are clinically significant with cyclosporine (amlodipine increases cyclosporine levels by up to 40%) and simvastatin (FDA recommends capping simvastatin at 20 mg when co-administered with amlodipine 10 mg) [3, 26].

The JNC 8 guideline, published in JAMA in 2014, recommended thiazide diuretics, ACE inhibitors, ARBs, or CCBs including amlodipine as first-line agents for hypertension in the general adult population, and as the preferred first-line drug for Black adults [27]. That guideline recommendation has driven formulary placement decisions by DC Medicaid and commercial plans, directly supporting Tier 1 classification and the low cost patients experience.

Renal dosing adjustment is not required for amlodipine because it is hepatically metabolized. Patients with chronic kidney disease in DC, a population with high rates of hypertension, can use standard doses without modification, eliminating any cost complexity around dose adjustment [28].

Step-by-Step: Getting the Lowest Amlodipine Price in DC

DC residents can minimize out-of-pocket costs with a direct sequence of steps.

First, confirm the diagnosis. Amlodipine is indicated for hypertension (systolic BP above 130 mmHg on two separate readings per AHA/ACC 2017 guideline criteria) or for angina [4]. Telehealth diagnosis is valid in DC.

Second, request generic amlodipine specifically. Ask the prescriber to write "generic substitution permitted" or simply "amlodipine besylate" rather than "Norvasc." Pharmacies default to generic unless the prescriber specifies otherwise, but clarity avoids errors.

Third, check GoodRx or a similar aggregator for the lowest DC pharmacy price before filling. Prices vary by up to $6 per fill across DC ZIP codes at different pharmacy chains. A 90-day supply (where permitted by insurance) typically costs less per dose than three separate 30-day fills.

Fourth, apply for DC Medicaid if income-eligible (household income up to 215% FPL for adults). Approval eliminates most or all cost. DC Medicaid applications are processed through Access DC, the district's unified eligibility portal [29].

Fifth, if DC Medicaid is unavailable and income is limited, contact Unity Health Care or Community of Hope, both 340B-covered FQHCs in DC, for low-cost or no-cost prescribing and dispensing [21].

Sixth, for patients already using a telehealth cardiovascular or metabolic program, confirm whether the program's compounded amlodipine bundle applies. If the program uses a licensed DC 503A pharmacy and the prescriber is licensed in DC, the cost may be $0 under the program's subscription fee [7].

What the 2026 DC Drug Price Environment Means for Amlodipine Patients

The Inflation Reduction Act authorizes Medicare to negotiate prices directly with manufacturers for certain high-cost drugs beginning in 2026 [17]. Amlodipine, being a long-genericized drug with a market price already near $8 per month, is not on the negotiation list and is not expected to see price changes from that policy.

DC's Council has also passed the Prescription Drug Price Transparency Act, which requires pharmaceutical manufacturers to report price increases above 10% annually for drugs with launch prices above $100 [30]. Amlodipine's generic price is well below that threshold, so DC price-transparency reporting obligations do not materially affect patient access.

Private equity consolidation of pharmacy benefit managers (PBMs) remains a background pricing factor. The Federal Trade Commission's 2024 report on PBM practices noted that spread pricing by PBMs can affect generic drug costs at independent pharmacies [31]. DC residents using small independent pharmacies should compare prices against GoodRx contracted rates to ensure they are not paying inflated spread-priced amounts. The $8 average reflects major chain and GoodRx-participating pharmacy pricing; individual independent pharmacies without discount card contracts may charge more.

Mail-order pharmacy remains a cost-effective channel. For DC residents with DC Medicaid or commercial insurance requiring 90-day supplies through mail order, cost per dose drops further. CVS Caremark, Express Scripts, and OptumRx all serve DC zip codes and offer mail-order generic amlodipine at Tier 1 rates under most plan designs [32].